华润医药(03320.HK)委任刘长安为执行董事

Group 1 - The core point of the article is the announcement of leadership changes at China Resources Pharmaceutical Group (华润医药), with Deng Rong resigning as an executive director and executive committee member, effective September 18, 2025, and Liu Chang'an being appointed as an executive director and executive committee member [1]